Skip to content
SK Pharmteco
-
SK Pharmteco opens two new manufacturing facilities at Swords Campus in Ireland
This expansion enhances its capability to produce high-potency active pharmaceutical ingredients (HPAPIs), antibody-drug conjugate (ADC) payloads, and commercial small-molecule APIs.
-
SK Pharmteco establishes advanced viral vector manufacturing facility in France
The site can produce up to 40 CGMP batches annually, supporting parallel processing for multiple client programs and ensuring reliable supply chains.